14.39p+0.39 (+2.79%)14 Feb 2025, 16:09
Jump to:
Futura Medical PLC Fundamentals
Company Name | Futura Medical PLC | Last Updated | 2025-02-14 |
---|---|---|---|
Industry | Biotechnology | Sector | Healthcare |
Shares in Issue | 303.830 m | Market Cap | £43.72 m |
PE Ratio | 0.00 | Dividend per Share | 0 |
Dividend Yield | 0 | Dividend Cover | 0 |
EPS | -£0.02 | EPS Growth (%) | 0 |
PEG | 0 | DPS Growth (%) | 0 |
Debt Ratio | 0 | Debt Equity Ratio | 0 |
Asset Equity Ratio | 1.2122 | Cash Equity Ratio | 0.5020 |
Quick Ratio | 3.3226 | Current Ratio | 3.75 |
Price To Book Value | 5.5991 | ROCE | 0 |
Futura Medical PLC Dividends
Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
---|
Futura Medical PLC Company Financials
Assets | 2023 | 2022 |
---|---|---|
Tangible Assets | £2.48 m | £1.16 m |
Intangible Assets | 0 | 0 |
Investments | 0 | 0 |
Total Fixed Assets | £2.48 m | £1.16 m |
Stocks | £339.00 | 0 |
Debtors | £1.15 m | £70,114.00 |
Cash & Equivalents | £7.71 m | £4.03 m |
Other Assets | 0 | 0 |
Total Assets | £11.82 m | £6.47 m |
Liabilities | 2023 | 2022 |
---|---|---|
Creditors within 1 year | £6.34 m | £1.75 m |
Creditors after 1 year | 0 | 0 |
Other Liabilities | 0 | 0 |
Total Liabilities | £6.34 m | £1.75 m |
Net assets | £5.48 m | £4.72 m |
Equity | 2023 | 2022 |
---|---|---|
Called up share capital | £602,812.00 | £576,093.00 |
Share Premium | £71.07 m | £66.55 m |
Profit / Loss | -£6.89 m | -£6.87 m |
Other Equity | £5.48 m | £4.72 m |
Preference & Minorities | 0 | 0 |
Total Capital Employed | £5.48 m | £4.72 m |
Ratios | 2023 | 2022 |
---|---|---|
Debt Ratio | 0 | 0 |
Debt-to-Equity | 0 | 0 |
Assets / Equity | 1.2122 | 1.2122 |
Cash / Equity | 0.5020 | 0.5020 |
EPS | -£0.02 | -£0.02 |
Cash Flow | 2023 | 2022 |
---|---|---|
Cash from operating activities | £570,253.00 | -£5.78 m |
Cashflow before financing | £5.12 m | -£5.61 m |
Increase in Cash | £3.69 m | -£6.35 m |
Income | 2023 | 2022 |
---|---|---|
Turnover | £3.10 m | 0 |
Cost of sales | £1.33 m | 0 |
Gross Profit | £1.77 m | 0 |
Operating Profit | -£6.96 m | -£6.87 m |
Pre-Tax profit | -£6.89 m | -£6.87 m |
Futura Medical PLC Company Background
Sector | Healthcare |
---|---|
Activities | Futura Medical PLC is engaged in the development and commercialization of sexual health products. Its product Eroxon is a treatment for erectile dysfunction. Geographically, the company derives a majority of its revenue from the United Kingdom and the European Union. |
Latest Interim Date | 10 Sep 2024 |
Latest Fiscal Year End Date | 10 Apr 2024 |
Futura Medical PLC Directors
Appointed | Name | Position |
---|---|---|
2025-01-13 | Mr. Jeffrey Robert Needham | Non-Executive Director,Chairman |
2023-07-18 | Mr. John Milne Clarke | Non-Executive Director,Chairman |
2016-03-31 | Ms. Lisa Arnold | Non-Executive Director |
2012-02-01 | Dr. William Duncan Potter | Executive Director,Chairman |
2025-01-13 | Mr. Andrew Vaughan Unitt | Non-Executive Director,Senior Independent Director |
2024-09-13 | Mr. James Henry Barder | Executive Director,Chief Executive |
2021-12-29 | Mr. Jonathan David Freeman | Non-Executive Director,Senior Independent Director |
2015-03-28 | Mr. David Bryn Davies | Executive Director,Chief Development Officer |
2018-04-09 | Mr. Derek Adrian Martin | Executive Director,Finance Director and Company Secretary |
2011-08-09 | Mr. Anthony Louis Clayden BSc,FCA,MSI | Executive Director,Finance Director and Company Secretary |
2024-09-13 | Mr. Kenneth William James | Executive Director,Head of RandD |
2024-04-29 | Ms. Angela Hildreth | Executive Director,Finance Director, Chief Operating Officer and Company Secretary |
2025-01-13 | Mr. Gordon Roy Davis | Non-Executive Director |
Futura Medical PLC Contact Details
Company Name | Futura Medical PLC |
---|---|
Address | 40 Occam Road, Surrey Technology Centre, Guildford, GU2 7YG |
Telephone | +44 1483685670 |
Website | https://www.futuramedical.com |
Futura Medical PLC Advisors
Auditor | KPMG |
---|---|
Phone | +44 1189642000 |
Fax | +44 1189642222 |
Bank | HSBC Bank PLC |
---|
Solicitor | Withers & Rogers LLP |
---|---|
Phone | +44 2079403600 |
Fax | +44 2073789680 |
Stockbroker | N+1 Singer |
---|---|
Phone | +44 2074963000 |
Fax | +44 2074963150 |
Nominated Adviser | N+1 Singer |
---|---|
Phone | +44 2074963000 |
Fax | +44 2074963150 |
Registrar | Capita Asset Services |
---|---|
Phone | +44 8716640300 |
Fax | +44 2086392342 |
Financial PR Adviser | Buchanan |
---|---|
Phone | +44 2074665000 |
Fax | +44 2074665001 |
Solicitor | Memery Crystal |
---|---|
Phone | +44 2072425905 |
Fax | +44 2072422058 |
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
![Sharesmagazine cover](/images/daily-email-mag-cover.jpg)
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
Company | Price | % Chg |
---|---|---|
Xps Pensions Group PLC | 390.00 | 12.39 |
Entain PLC | 744.40 | 6.77 |
Hochschild Mining PLC | 202.00 | 4.99 |
Assura PLC | 39.00 | 4.17 |
Fidelity China Special Situations PLC | 253.00 | 4.12 |
Ferrexpo PLC | 96.40 | 3.54 |
Fallers
Company | Price | % Chg |
---|---|---|
Wood Group (John) PLC | 29.00 | -55.62 |
Mitchells & Butlers PLC | 225.50 | -3.63 |
Schroders PLC | 371.60 | -3.13 |
Ncc Group PLC | 136.00 | -2.58 |
International Consolidated Airlines Group S.A. | 338.50 | -2.56 |
Trainline PLC | 355.00 | -2.15 |
Risers/fallers data from previous trading day.